Omeros Corporation
OMERDrugs in Pipeline
13
Phase 3 Programs
5
Upcoming Catalysts
1
Next Catalyst
Dec 15, 2026
39wMarket Overview
Stock performance and key metrics
2 upcoming, 0 past
OMS103HP
Anterior Cruciate Ligament Reconstruction
OMS103HP-S
Meniscal Tear
Vehicle
Postoperative Pain
OMS302
Intraocular Lens Replacement
Phenylephrine HCl
Unilateral Cataract Extraction
OMS906 study drug
Paroxysmal Nocturnal Hemoglobinuria
Biological: narsoplimab
Thrombotic Microangiopathies
OMS302-PE
Cataract Extraction
OMS906
Paroxysmal Nocturnal Hemoglobinuria
OMS201
Urinary Calculi
OMS643762
Schizophrenia
OMS302 Solution
Cataract
OMS721
Thrombotic Microangiopathies
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
OMS103HP | Phase 3 | Anterior Cruciate Ligament Reconstruction | - | - |
OMS103HP-S | Phase 3 | Meniscal Tear | - | - |
Vehicle | Phase 3 | Postoperative Pain | - | - |
OMS302 | Phase 3 | Intraocular Lens Replacement | - | - |
Phenylephrine HCl | Phase 3 | Unilateral Cataract Extraction | - | - |
OMS906 study drug | Phase 2 | Paroxysmal Nocturnal Hemoglobinuria | - | - |
Biological: narsoplimab | Phase 2 | Thrombotic Microangiopathies | - | - |
OMS302-PE | Phase 2 | Cataract Extraction | - | - |
OMS906 | Phase 2 | Paroxysmal Nocturnal Hemoglobinuria | - | - |
OMS201 | Phase 2 | Urinary Calculi | - | - |
OMS643762 | Phase 2 | Schizophrenia | - | - |
OMS302 Solution | Phase 2 | Cataract | - | - |
OMS721 | Phase 2 | Thrombotic Microangiopathies | - | - |